Drugs / LEO 27989
last change Apr 2011 re-read 2 minutes ago

LEO 27989

Developed for
psoriasis
Investigated by
LEO Pharma

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01297166 Feb → Apr 2011 psoriasis LEO Pharma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LEO 27989 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01297166
Route Topical “LEO 27989 ointment” NCT01297166